Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term **anticonvulsant** refers to a pharmacological class of drugs that prevent or reduce the severity and frequency of epileptic seizures. These agents are highly diverse—acting on multiple molecular targets such as voltage-gated sodium channels, calcium channels, GABA receptors, GABA transaminase, SV2A (synaptic vesicle protein), and others. As a group, anticonvulsants are used principally for the treatment of epilepsy, but some are also used for mood stabilization and neuropathic pain. Because "anticonvulsant" is a drug class and not a single molecular entity or receptor, it cannot be specified as a molecular drug target[3][1][2][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anticonvulsant.